Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Faculty of Health Sciences launches guiding documents
2007-05-31

 

The Faculty of Health Sciences at the University of the Free State (UFS) has launched two guiding documents for medical students for the years 2000 (phase one) and 2004 (phase two). The faculty has been offering a five-year M.B.Ch.B degree since 2000 and subsequently revised the curriculum in 2004 to comply with international developments. As a result, guiding documents detailing the academic and administrative regulations for each phase were compiled. At the launch were, from the left, front: Dr Brenda de Klerk (Phase I chairperson), Prof Elsa de Wet (Phase II chairperson) and Prof Laurika van der Westhuizen (Programme Director); back from left: Prof Gert van Zyl (Head: School of Medicine) and Dr Hennie Geyer (Phase II chairperson)
Photo: Leonie Bolleurs
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept